Thanks to our extensive experience in the field of injectable medications and the dedicated work of our team, we develop high-quality products.
We believe in collaboration as a driver of growth and seek strategic alliances with international companies to expand our global market impact.
We work with partners worldwide to bring innovative solutions to more patients, expanding our reach and creating shared value.
Collaborating with other companies is key to our business model.
Our international strategy is based on a business-to-business (B2B) model, establishing partnerships with reliable pharmaceutical companies at local, regional, and global levels.
Developing these collaborations ensures our products are available to patients worldwide.
Our national strategy is based on a
business-to-customer (B2C) model.
The combination of our own injectable products and licensed products from other companies allows us to offer a variety of therapies in the areas of Urology, Oncology, Women’s Health, as well as hospital products.
We are committed to offer innovative and generic products to Spanish society and the National Health Sector.
Discover in detail our portfolio of injectable products and their application in different therapeutic areas.
